Postmenopausal women with obesity are at heightened risk of developing nonvertebral fractures in the presence of type 2 diabetes mellitus (T2DM), a study has found.
The study included 679 postmenopausal women (mean age 60.6 years, mean weight 66 kg) with a mean body mass index (BMI) of 27 kg/m2, among whom 186 had obesity (mean BMI 33.8 kg/m2) and 81 had T2DM.
Researchers assessed serum levels of 25(OH)-vitamin D and parathyroid hormone (PTH), as well as bone mineral density (BMD) and prevalent fragility fractures.
Compared with nonobese controls, obese women were older (mean age 59.0 vs 64.8 years; p<0.001) and had a higher prevalence of T2DM (9.9 percent vs 17.2 percent; p=0.009), higher PTH levels (42.1 vs 54.9 pg/mL; p<0.001), and lower 25(OH)-vitamin D levels (23.0 vs 20.8 ng/mL; p<0.001).
Furthermore, the obese group had higher BMD values at the lumbar spine (0.905 vs 0.831 g/cm2; p<0.001), femoral neck (0.736 vs 0.635 g/cm2; p<0.001), and total hip (0.887 vs 0.758 g/cm2; p<0.001).
In the group of women with obesity, nonvertebral fractures were more prevalent among those with vs without T2DM (45 vs 20; p<0.001). Multivariate logistic regression analysis revealed that fragility fractures were associated with age, total hip BMD, BMI, and T2DM.
The findings indicate that comorbid obesity and T2DM is a risk factor for nonvertebral fragility fractures.